CAI Caris Life Sciences, Inc.

Fundamentals / CIK 0002019410 / USD

Caris Life Sciences, Inc. reported $1.05B in revenue and net income of $96.06M for the trailing twelve months ended September 30, 2026 (up 27.0% year over year), with a 13.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CAI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$836.4M$418.2M$0-$388.2MFY 2023 Revenue: $306.1MFY 2023 Net Income: -$341.4M2023FY 2024 Revenue: $412.3MFY 2024 Net Income: -$281.9M2024FY 2025 Revenue: $812.0MFY 2025 Net Income: -$68.09M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $812.0M $412.3M $306.1M
Research & Development $101.6M $113.9M $116.9M
Selling, General & Admin $392.5M $322.0M $292.0M
Operating Income $45.11M -$257.1M -$319.6M
EBITDA $67.73M -$208.2M -$270.6M
Interest Income $16.50M $7.12M $11.26M
Interest Expense $56.85M $50.02M $31.61M
Income Before Tax -$68.09M -$281.9M -$341.4M
Income Tax Expense $0 $0 $0
Net Income -$68.09M -$281.9M -$341.4M
Basic EPS -$3.22 -$10.66 -$13.24
Diluted EPS -$3.22 -$10.66 -$13.24
Basic Shares Outstanding 167.2M 35.5M 34.9M
Diluted Shares Outstanding 167.2M 35.5M 34.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Revenue $275.4M $263.7M $216.2M $292.9M $216.8M $181.4M $120.9M $101.6M
Research & Development $33.84M $32.36M $31.32M $31.84M $21.62M $25.05M $23.07M $27.64M
Selling, General & Admin $129.1M $120.3M $104.8M $100.7M $93.24M $106.6M $91.95M $77.61M
Operating Income $19.32M $26.93M $5.28M $88.41M $32.64M -$17.99M -$57.95M -$60.84M
EBITDA $25.92M $33.43M $10.35M $92.70M $37.54M -$11.59M -$50.91M -$50.34M
Interest Income $6.33M $6.82M $6.83M $7.01M $7.36M $1.62M $503K $1.74M
Interest Expense $9.25M $9.23M $12.81M $11.36M $13.51M $19.21M $12.78M $13.80M
Income Before Tax $16.87M -$614K -$644K $81.96M $24.32M -$71.79M -$102.6M -$67.73M
Income Tax Expense $1.62M $23K -$134K $0 $0 $0 $0 $0
Net Income $15.25M -$637K -$510K $81.96M $24.32M -$71.79M -$102.6M -$67.73M
Basic EPS $0.05 $0.00 $0.00 -- $0.09 -$7.97 -$3.57 -$2.59
Diluted EPS $0.05 $0.00 $0.00 -- $0.08 -$7.97 -$3.57 -$2.59
Basic Shares Outstanding 283.9M 282.9M 282.6M -- 282.1M 64.9M 35.6M 35.6M
Diluted Shares Outstanding 295.1M 282.9M 282.6M -- 297.2M 64.9M 35.6M 35.6M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $796.3M $63.95M
Short-Term Investments $2.29M $2.20M
Cash & Short-Term Investments $798.6M $66.15M
Accounts Receivable, Net $112.1M $88.24M
Other Current Assets $2.35M $6.71M
Total Current Assets $997.8M $215.7M
Property, Plant & Equipment, Net $63.17M $67.82M
Goodwill $19.34M $19.34M
Other Non-Current Assets $45.35M $40.84M
Total Non-Current Assets $127.9M $128.0M
Total Assets $1.13B $343.7M
Accounts Payable $39.21M $27.79M
Short-Term Debt $169K $60.09M
Deferred Revenue (Current) $24.49M $7.47M
Total Current Liabilities $127.1M $165.4M
Long-Term Debt $378.8M $319.4M
Deferred Revenue (Non-Current) $0 --
Other Non-Current Liabilities $42.39M $44.42M
Total Non-Current Liabilities $421.2M $455.5M
Total Liabilities $548.4M $620.9M
Total Debt (incl. Leases) $428.2M $424.6M
Common Stock $283K $38K
Retained Earnings -$2.55B -$2.47B
Accumulated Other Comp. Income $936K $210K
Total Stockholders' Equity $577.3M -$2.50B
Total Equity $577.3M -$2.50B

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2024-12-31
Cash & Cash Equivalents -- -- $819.9M $796.3M $753.2M $718.9M $63.95M
Short-Term Investments $102.1M $102.2M $2.31M $2.29M $2.27M $2.25M $2.20M
Cash & Short-Term Investments -- -- $822.2M $798.6M $755.5M $721.2M $66.15M
Accounts Receivable, Net $133.3M $116.9M $90.52M $112.1M $26.70M $50.89M $88.24M
Other Current Assets $4.91M $5.11M $4.29M $2.35M $2.58M $2.55M $6.71M
Total Current Assets $1.07B $1.06B $1.01B $997.8M $854.2M $833.3M $215.7M
Property, Plant & Equipment, Net $102.3M $95.72M $82.67M $63.17M $64.00M $61.31M $67.82M
Goodwill $19.34M $19.34M $19.34M $19.34M $19.34M $19.34M $19.34M
Other Non-Current Assets $66.72M $56.73M $46.20M $45.35M $46.98M $41.08M $40.84M
Total Non-Current Assets $188.4M $171.8M $148.2M $127.9M $130.3M $121.7M $128.0M
Total Assets $1.26B $1.23B $1.16B $1.13B $984.6M $955.1M $343.7M
Accounts Payable $63.84M $85.99M $69.80M $39.21M $29.00M $28.73M $27.79M
Short-Term Debt $89K $178K $173K $169K $164K $95K $60.09M
Deferred Revenue (Current) $18.37M $20.52M $24.97M $24.49M $2.79M $5.34M $7.47M
Total Current Liabilities $158.9M $191.4M $143.9M $127.1M $86.03M $90.18M $165.4M
Long-Term Debt $393.2M $393.0M $381.4M $378.8M $376.3M $373.6M $319.4M
Deferred Revenue (Non-Current) $552K $539K -- $0 -- -- --
Other Non-Current Liabilities $64.02M $53.48M $43.60M $42.39M $43.88M $38.36M $44.42M
Total Non-Current Liabilities $457.2M $446.4M $425.0M $421.2M $420.2M $412.0M $455.5M
Total Liabilities $616.1M $637.9M $568.9M $548.4M $506.2M $502.2M $620.9M
Total Debt (incl. Leases) $463.0M $452.4M $431.0M $428.2M $426.7M $419.0M $424.6M
Common Stock $287K $283K $284K $283K $283K $282K $38K
Retained Earnings -$2.53B -$2.55B -$2.55B -$2.55B -$2.63B -$2.66B -$2.47B
Accumulated Other Comp. Income -$105K $529K $893K $936K $748K $669K $210K
Total Stockholders' Equity $639.5M $591.7M $593.5M $577.3M $478.4M $452.9M -$2.50B
Total Equity $639.5M $591.7M $593.5M $577.3M $478.4M $452.9M -$2.50B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$68.09M -$281.9M -$341.4M
Depreciation & Amortization $22.61M $48.91M $49.00M
Stock-Based Compensation $70.01M $18.64M $15.24M
Change in Receivables -$29.79M -$33.82M -$15.08M
Change in Payables $11.04M -$226K $7.17M
Operating Cash Flow $83.16M -$245.2M -$276.1M
Capital Expenditure -$16.26M -$8.44M -$22.32M
Free Cash Flow $66.89M -$253.6M -$298.4M
Purchases of Investments $0 $0 -$63.40M
Investing Cash Flow -$16.26M $52.93M $214.8M
Share Repurchases -$113K $0 $0
Financing Cash Flow $665.0M $200.3M $10.13M
Net Change in Cash $732.0M $8.02M -$51.13M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Net Income $15.25M -$637K -$510K $81.96M $24.32M -$71.79M -$102.6M -$67.73M
Depreciation & Amortization $6.60M $6.50M $5.07M $4.29M $4.90M $6.40M $7.04M $10.50M
Stock-Based Compensation $18.50M $22.22M $15.87M $13.37M $13.65M $28.29M $14.69M $4.72M
Change in Receivables -$16.43M -$26.37M $21.62M -$91.02M $24.19M $29.13M $7.91M --
Change in Payables -$21.59M $23.26M $16.37M $12.23M $729K -$186K -$1.74M --
Operating Cash Flow -$22.25M $28.48M $32.88M $44.78M $62.42M $7.29M -$31.34M --
Capital Expenditure -- -- -$10.34M -$5.09M -$7.09M -$1.39M -$2.69M --
Free Cash Flow -- -- $22.53M $39.69M $55.33M $5.90M -$34.03M --
Investing Cash Flow -$17.47M -$122.2M -$10.34M -$5.09M -$7.09M -$1.39M -$2.69M --
Share Repurchases -$10.01M -$21.36M $0 -$91K $0 $0 -$22K --
Financing Cash Flow $14.23M -$36.90M $824K $3.40M -$21.10M $681.4M $1.28M --
Net Change in Cash -$25.59M -$130.6M $23.35M $43.06M $34.30M $687.4M -$32.74M --

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin 5.6% -62.4% -104.4%
Net Profit Margin -8.4% -68.4% -111.5%
Return on Equity (ROE) -11.8% -- --
Return on Assets (ROA) -6.0% -82.0% --
Current Ratio 7.85x 1.30x --
Quick Ratio 7.16x 0.93x --
Debt to Equity 0.74x -- --
Revenue Growth (YoY) +97.0% +34.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Operating Margin 13.4% 15.5% 11.9% 5.6% -- -- -- --
Net Profit Margin 9.2% 10.6% 3.7% -8.4% -- -- -- --
Return on Equity (ROE) 15.0% 17.8% 5.7% -11.8% -- -- -- --
Return on Assets (ROA) 7.7% 8.6% 2.9% -6.0% -- -- -- --
Current Ratio 6.71x 5.53x 7.05x 7.85x 9.93x 9.24x -- --
Quick Ratio -- -- 6.34x 7.16x 9.09x 8.56x -- --
Debt to Equity 0.72x 0.76x 0.73x 0.74x 0.89x 0.93x -- --
Revenue Growth (YoY) +27.0% +45.4% +78.8% -- +113.4% +81.3% -- --
Operating Income Growth (YoY) -40.8% -- -- -- -- -- -- --
Net Income Growth (YoY) -37.3% -- -- -- -- -- -- --
EPS Growth (YoY) -44.4% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -135.6% +290.7% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002019410) · from December 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:12 UTC · Open in terminal